Multi-center prospective study about the clinical significance of the measurement of faecal calprotectin for inflammatory bowel disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1092220180

Enrollment

180

Registered

2014-06-02

Start date

2013-02-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel diseases

Interventions

Intervention type:DEVICE Name of intervention:measurement of fecal calprotectin Dose form / Japanese Medical Device Nomenclature:NOT APPLICABLE Route of administration / Site of application:NOT APPLIC

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with IBD who performed ileocolonoscopy

Exclusion criteria

Exclusion criteria: imcomplete colonoscopy, difficulty to collect fecal sample,stoma, and so on

Design outcomes

Primary

Measure	Time frame
Fecal calprotectin, clinical activity index, endoscopic activity index(UC:sum of Mayo endoscopic subscore, CD:SES-CD)	—

Secondary

Measure	Time frame
Evaluation of both fecal calprotectin and endoscopic activity as a predicting marker of relapse in patients with clinical remission of IBD.	—

Contacts

Public ContactKousaku Kawashima

Shimane University School of Medicine

kk461223@med.shimane-u.ac.jp+81-853-20-2190

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026